Letter | Published:

Eyes absent represents a class of protein tyrosine phosphatases

Abstract

The Eyes absent proteins are members of a conserved regulatory network implicated in the development of the eye, muscle, kidney and ear1,2,3,4,5,6,7. Mutations in the Eyes absent genes have been associated with several congenital disorders including the multi-organ disease bronchio-oto-renal syndrome8, congenital cataracts9 and late-onset deafness10. On the basis of previous analyses it has been shown that Eyes absent is a nuclear transcription factor, acting through interaction with homeodomain-containing Sine oculis (also known as Six) proteins11. Here we show that Eyes absent is also a protein tyrosine phosphatase. It does not resemble the classical tyrosine phosphatases that use cysteine as a nucleophile and proceed by means of a thiol-phosphate intermediate12. Rather, Eyes absent is the prototype for a class of protein tyrosine phosphatases that use a nucleophilic aspartic acid in a metal-dependent reaction. Furthermore, the phosphatase activity of Eyes absent contributes to its ability to induce eye formation in Drosophila.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Desplan, C. Eye development: governed by a dictator or a junta? Cell 91, 861–864 (1997)

  2. 2

    Xu, P. X. et al. Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development 129, 3033–3044 (2002)

  3. 3

    Borsani, G. et al. EYA4, a novel vertebrate gene related to Drosophila eyes absent. Hum. Mol. Genet. 8, 11–23 (1999)

  4. 4

    Heanue, T. A. et al. Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation. Genes Dev. 13, 3231–3243 (1999)

  5. 5

    Xu, P. X., Woo, I., Her, H., Beier, D. R. & Maas, R. L. Mouse Eya homologues of the Drosophila eyes absent gene require Pax6 for expression in lens and nasal placode. Development 124, 219–231 (1997)

  6. 6

    Xu, P. X., Cheng, J., Epstein, J. A. & Maas, R. L. Mouse Eya genes are expressed during limb tendon development and encode a transcriptional activation function. Proc. Natl Acad. Sci. USA 94, 11974–11979 (1997)

  7. 7

    Xu, P. X. et al. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nature Genet. 23, 113–117 (1999)

  8. 8

    Abdelhak, S. et al. Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum. Mol. Genet. 6, 2247–2255 (1997)

  9. 9

    Azuma, N., Hirakiyama, A., Inoue, T., Asaka, A. & Yamada, M. Mutations of a human homologue of the Drosophila eyes absent gene (EYA1) detected in patients with congenital cataracts and ocular anterior segment anomalies. Hum. Mol. Genet. 9, 363–366 (2000)

  10. 10

    Wayne, S. et al. Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum. Mol. Genet. 10, 195–200 (2001)

  11. 11

    Ohto, H. et al. Cooperation of Six and Eya in activation of their target genes through nuclear translocation of Eya. Mol. Cell. Biol. 19, 6815–6824 (1999)

  12. 12

    Charbonneau, H. & Tonks, N. K. 1002 protein phosphatases? Annu. Rev. Cell Biol. 8, 463–493 (1992)

  13. 13

    Pignoni, F. et al. The eye-specification proteins So and Eya form a complex and regulate multiple steps in Drosophila eye development. Cell 91, 881–891 (1997)

  14. 14

    Chen, R., Amoui, M., Zhang, Z. & Mardon, G. Dachshund and eyes absent proteins form a complex and function synergistically to induce ectopic eye development in Drosophila. Cell 91, 893–903 (1997)

  15. 15

    Fan, X. et al. The alpha subunits of Gz and Gi interact with the eyes absent transcription cofactor Eya2, preventing its interaction with the six class of homeodomain-containing proteins. J. Biol. Chem. 275, 32129–32134 (2000)

  16. 16

    Aravind, L., Galperin, M. Y. & Koonin, E. V. The catalytic domain of the P-type ATPase has the haloacid dehalogenase fold. Trends Biochem. Sci. 23, 127–129 (1998)

  17. 17

    Collet, J. F., Stroobant, V., Pirard, M., Delpierre, G. & Van Schaftingen, E. A new class of phosphotransferases phosphorylated on an aspartate residue in an amino-terminal DXDX(T/V) motif. J. Biol. Chem. 273, 14107–14112 (1998)

  18. 18

    Collet, J. F., Stroobant, V. & Van Schaftingen, E. Mechanistic studies of phosphoserine phosphatase, an enzyme related to P-type ATPases. J. Biol. Chem. 274, 33985–33990 (1999)

  19. 19

    Ridder, I. S. & Dijkstra, B. W. Identification of the Mg2+-binding site in the P-type ATPase and phosphatase members of the HAD (haloacid dehalogenase) superfamily by structural similarity to the response regulator protein CheY. Biochem. J. 339, 223–226 (1999)

  20. 20

    Morais, M. C. et al. The crystal structure of bacillus cereus phosphonoacetaldehyde hydrolase: insight into catalysis of phosphorus bond cleavage and catalytic diversification within the HAD enzyme superfamily. Biochemistry 39, 10385–10396 (2000)

  21. 21

    Ridder, I. S., Rozeboom, H. J., Kalk, K. H., Janssen, D. B. & Dijkstra, B. W. Three-dimensional structure of L-2-haloacid dehalogenase from Xanthobacter autotrophicus GJ10 complexed with the substrate-analogue formate. J. Biol. Chem. 272, 33015–33022 (1997)

  22. 22

    Zhang, Z. Y. et al. Substrate specificity of the protein tyrosine phosphatases. Proc. Natl Acad. Sci. USA 90, 4446–4450 (1993)

  23. 23

    Daum, G. et al. A general peptide substrate for protein tyrosine phosphatases. Anal. Biochem. 211, 50–54 (1993)

  24. 24

    Denu, J. M. et al. The purification and characterization of a human dual-specific protein tyrosine phosphatase. J. Biol. Chem. 270, 3796–3803 (1995)

  25. 25

    Bonini, N. M., Leiserson, W. M. & Benzer, S. The eyes absent gene: genetic control of cell survival and differentiation in the developing Drosophila eye. Cell 72, 379–395 (1993)

  26. 26

    Bui, Q. T., Zimmerman, J. E., Liu, H. & Bonini, N. M. Molecular analysis of Drosophila eyes absent mutants reveals features of the conserved Eya domain. Genetics 155, 709–720 (2000)

  27. 27

    Rubin, G. M. & Spradling, A. C. Genetic transformation of Drosophila with transposable element vectors. Science 218, 348–353 (1982)

  28. 28

    Spradling, A. C. & Rubin, G. M. Transposition of cloned P elements into Drosophila germ line chromosomes. Science 218, 341–347 (1982)

  29. 29

    Kango-Singh, M. et al. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129, 5719–5730 (2002)

  30. 30

    Pappu, K. S. et al. Mechanism of hedgehog signaling during Drosophila eye development. Development 130, 3053–3062 (2003)

Download references

Acknowledgements

We thank R. Lang and J. Schlessinger for discussions and comments on the manuscript. Mouse Eya1 cDNA was provided by T. Glaser and Drosophila eya cDNA was provided by N. Bonini.

Author information

Correspondence to Rashmi S. Hegde.

Ethics declarations

Competing interests

The authors declare that they have no competing financial interests.

Supplementary information

Supplementary Figure 1: Saturation kinetics for the ED domains of mouse Eya2 (d), Eya1 (e), Drosophila Eya (f) and full-length Arabidopsis Thaliana EYA (g). Rate of hydrolysis of substrate (pNPP) (assay buffer 20 mM MES pH 6, 2 mM MgCl2) is plotted against increasing substrate concentration. Data were fitted to the Michaelis-Menten equation, and the resulting kinetic parameters are indicated. (JPG 61 kb)

Supplementary Figure 2: Proposed mechanism for the phosphatase activity of Eyes Absent, by analogy with the HAD enzymes. Residues indicated in red belong to motif I, residues in green are from motif II, and residues in blue are form motif III. The substrate and cofactor are in black. The residue numbers refer to Eya3. (PDF 35 kb)

Supplementary Table 1: Mutational Analysis of Eyes Absent proteins (DOC 25 kb)

Supplementary Table 1: Activity of Eyes Absent proteins and control PTPs towards phosphorylated MyBP and a pY-containing peptide (DOC 20 kb)

Rights and permissions

Reprints and Permissions

About this article

Further reading

Figure 1: Eyes absent is a phosphatase.
Figure 2: Eya3(ED) can dephosphorylate proteins in a dose- and metal-dependent fashion.
Figure 3: The effect of inhibitors on the phosphatase activity of Eya3(ED).
Figure 4: Loss of phosphatase activity compromises Eya function in vivo.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.